For Immediate Release:  January 13, 2011
Contact:         Erica Neufeld
(240) 235-2201

Former Congresswoman Deborah Pryce Appointed
Vice Chair of the Board for CureSearch for Children's Cancer


Congresswoman has been a longtime supporter of this national children's cancer research foundation. 

Bethesda, MD – Former Ohio Congresswoman Deborah Pryce was named Vice Chair of the Board for CureSearch for Children's Cancer last week, a leading pediatric oncology research foundation. During her time in Congress, Pryce was instrumental in the writing and passage of the Conquer Childhood Cancer Act, in memory of her daughter Caroline who passed away in 1999 from neuroblastoma, a rare form of cancer.  Rep. Pryce is known for taking a common-sense, consensus-building approach to governing, leading Business Week magazine to dub her The Peacemaker.  The Columbus Dispatch described her as discreetly influential with a reputation as a quiet leader.  New York Times columnist David Brooks portrayed her as having an honest, inner voice.  She has a reputation for bipartisanship and bringing opposing sides to the table to negotiate solutions.

Rep. Pryce's work in Congress earned the acclaim of countless national organizations that recognized her as a leader on pediatric health and cancer initiatives.  Pryce served on the Speaker's Working Group on Managed Care Reform; co-chaired the House Cancer Caucus; and authored several health care bills, including the Conquer Childhood Cancer Act, legislation to establish a Children's Hospital Graduate Medical Education program, the Access to Cancer Clinical Trials Act, and the Patient Navigator Outreach and Chronic Disease Prevention Act.  She is also the co-founder of Hope Street Kids, a nonprofit organization that raises money for pediatric cancer research and treatment.

Pryce has been on the board of CureSearch for Children's Cancer since 2009 when Hope Street Kids became a program of CureSearch.  Along with funds raised through Hope Street Kids, CureSearch supports the cutting-edge research of the Children's Oncology Group, a collaborative research group of more than 210 member hospitals worldwide.  In the U.S., Children's Oncology Group member hospitals treat more than 90 percent of children with cancer.

“I couldn't be more thrilled to bring my Congressional expertise and passion for the cause together to help lead this organization.  The childhood cancer community has an obligation to kids to work together and share our responsibility to fight the fight together.  My goal is to seek consensus and find the common ground and there couldn't be a better platform from which to do it,” says Pryce.

 

-more-

 

Progress has been made in the survival rates of children's cancer in recent decades.  Forty years ago, the overall survival rate was approximately 20 percent and now it is nearly 80 percent. Still, more than 13,500 children are diagnosed each year and one in five children loses his or her battle with cancer.  Further, many children experience long-term effects from treatment, including secondary cancers. 

For 10 years, CureSearch has supported the research of the Children's Oncology Group by raising funds from its national office in Bethesda, MD. In the last year, CureSearch has expanded its operation to include five regional fundraising offices and the organization's revenue has increased significantly.  John Lehr, president and CEO of CureSearch for Children's Cancer, is excited about Pryce's new role and how it will help the organization move forward.  “Congresswoman Pryce has not only been instrumental in ensuring federal dollars are allocated to children's cancer research, but also recognizes the need for CureSearch to have a presence across the nation so that we can truly partner with the children's hospitals conducting research and the patients and families being treated at those hospitals,” said Lehr. 

Also appointed to a board leadership role today was Stuart Siegel, MD who will serve as Chair of the Board.  Dr. Siegel is the founding director of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles and has served as the Division Head of the Pediatric Hematology-Oncology program at the hospital for 34 years. He has also been Associate Director for Pediatric
Oncology at the USC/Norris Comprehensive Cancer Center for 20 years and oversaw the development of one of the largest pediatric translational cancer research programs in the nation and its integration into the scientific program of the Cancer Center, especially in the areas of Developmental Therapeutics, Tumor Microenvironment and Leukemia/Lymphoma.   In addition, Dr. Siegel is the Principal Investigator for the USC-CHLA Institute for Pediatric Clinical Research which conducts a drug development program for pediatric leukemias and lymphomas, pre-clinical efficacy studies and initial Phase 1 testing in
a 33-member international clinical trials consortium TACL.

 

# # #

 

About Congresswoman Deborah Pryce
Congresswoman Pryce co-founded Hope Street Kids, a program of CureSearch for Children's Cancer and during her time in Congress was instrumental in passage of the Caroline Pryce Walker Conquer Childhood Cancer Act.  This Act allows congress to allocate up to $30 million a year in children's cancer research to the National Cancer Institute.  Congresswoman Pryce is currently a Senior Public Policy Advisor for SZD Whiteboard, a consulting enterprise.

About CureSearch for Children's Cancer
CureSearch for Children's Cancer funds the lifesaving, collaborative research of the Children's Oncology Group, the largest children's cancer research organization in the world. With more than 6,500 physicians, nurses and researchers at more than 200 hospitals in North America and worldwide, this group treats 90 percent of children with cancer in the U.S.

Christine Bork
Email Christine
(800) 458-6223



Childhood Cancer

Medical Information

Research

Coping with Cancer

Get Involved

About Us